News

Mar 27, 2007 News

Orientoxin Biotech completes initial discussions with ReceptoPharm, Inc. to develop anti-HIV drugs for the Chinese market. Upon successful completion of the pre-clinical studies, ReceptoPharm and Orientoxin Biotech will proceed with clinical trials aimed at gaining full regulatory approval in China.

ʱ䣺2008-01-20 Back